Riskx Investments adds West Pharmaceutical Services (WST) to its portfolio

West Pharmaceutical Services (WST) : Riskx Investments added new position in West Pharmaceutical Services during the most recent quarter end. The investment management firm now holds 9,730 shares of West Pharmaceutical Services which is valued at $787,741 , the company said in a statement filed on Aug 1, 2016 with the SEC.West Pharmaceutical Services makes up approximately 0.67% of Riskx Investments’s portfolio.

Other Hedge Funds, Including , National Investment Services Inc Wi added WST to its portfolio by purchasing 3,486 company shares during the most recent quarter which is valued at $273,407. West Pharmaceutical Services makes up approx 0.30% of National Investment Services Inc Wi’s portfolio. Parametrica Management Ltd added WST to its portfolio by purchasing 4,539 company shares during the most recent quarter which is valued at $354,133. West Pharmaceutical Services makes up approx 0.51% of Parametrica Management Ltd’s portfolio.Ruane Cunniff Goldfarb Inc reduced its stake in WST by selling 90,631 shares or 16.98% in the most recent quarter. The Hedge Fund company now holds 443,019 shares of WST which is valued at $34,311,822. West Pharmaceutical Services makes up approx 0.32% of Ruane Cunniff Goldfarb Inc’s portfolio.

West Pharmaceutical Services opened for trading at $81.16 and hit $81.86 on the upside on Thursday, eventually ending the session at $81.5, with a gain of 0.67% or 0.54 points. The heightened volatility saw the trading volume jump to 2,77,759 shares. Company has a market cap of $5,956 M.

On the company’s financial health, West Pharmaceutical Services reported $0.60 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.56. The company had revenue of $388.00 million for the quarter, compared to analysts expectations of $384.58 million. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.47 EPS.

West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

West Pharmaceutical Services - Is it time to Sell?

Top Brokerage Firms are advising their investors on West Pharmaceutical Services. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.